Results 31 to 40 of about 58,793 (273)
Biomedicine & Pharmacotherapy, 1995 Benign prostatic hypertrophy (BPH) is one of the most common diseases of adult males which increases with age. Effective therapeutic agents are an attractive option for patients for whom surgery is not a necessity, improving quality of life when compared with watchful waiting.
P, Roylance, B, Gibelin, J, Espié
openaire +2 more sources
Mean values of Accuracy, Specificity and Sensitivity for the classifications of PCa vs. Normal, BPH vs. Normal, PCa vs. BPH, and PCa (PSA>4.0) vs. BPH (PSA>4.0). [PDF]
, 2015 Mean values of Accuracy, Specificity and Sensitivity for the classifications of PCa vs. Normal, BPH vs. Normal, PCa vs. BPH, and PCa (PSA>4.0) vs. BPH (PSA>4.0).
Petra Leidinger (191756) +11 more
core +1 more source
Société Internationale d’Urologie Journal, 2021 The lower urinary tract (LUT), in particular the prostate, has been theoretically recognized as a target for SARS-CoV-2. Moreover, common pathophysiological mechanisms have been described for BPE/LUTS and COVID-19, including RAS dysregulation, androgen ...
Dean Elterman +8 more
doaj +1 more source
Androloji Bülteni, 2023 Benign prostatic hyperplasia (BPH) is histological changes in the prostate that result in increased prostate volume and lower urinary tract symptoms. Although there are several reasons for the development of LUTS in BPH, the most important reason is the enlargement of the prostate gland.
Atan, Ali, Bulut, Ender Cem
openaire +2 more sources
Combination therapy for benign prostate hyperplasia-related urinary symptoms
Вестник урологии, 2022 Introduction. Non-neurogenic lower urinary tract symptoms (LUTS) are a serious polyetiologic problem in the male population. The side effects of the medication agents used to treat LUTS significantly reduce treatment compliance.
S. V. Shkodkin +6 more
doaj +1 more source
Outcome of management of patients with BPH and vesical calculi [PDF]
, 2023 INTRODUCTION: The complications of benign prostatic hyperplasia (BPH) among others include bladder stones. The prevalence of vesical calculus is eight times higher in men having BPH (3.4%) as compared with men without BPH (0.4%).
Keyur Patel +4 more
core +1 more source
EAU guidelines on benign prostatic hyperplasia (BPH) [PDF]
, 2001 Objective:To establish guidelines for the diagnosis, treatment, and follow-up of BPH. Methods:A search of published work was conducted using Medline. In combination with expert opinions, recommendations were made on the usefulness of tests for assessment
Thomas, D +6 more
core +3 more sources
The function of OsRCI in rice resistance to BPH(20220416) [PDF]
, 2022 The function of OsRCI in rice resistance to BPH(20220416): Subcellular location of OsRCI-1; Relative expression level of OsRCI; Phenotypes of over-expression OsRCI-1 rice (oeRCI-1 lines); Rice brown planthopper (BPH) behavior to oeRCI lines;
Guoxin Zhou (12423808)
core +1 more source
Associations of circulating vitamins with 10-year retinal neurodegeneration: the Alienor Study
The Journal of Nutrition, Health and AgingObjective: To investigate the associations between circulating vitamins A, D, E, B6, B9, B12 and longitudinal changes in retinal nerve fiber layer (RNFL) thickness.
Bénédicte MJ Merle +7 more
doaj +1 more source
Management of BPH then 2000 and now 2016 – From BPH to BPO
Asian Journal of Urology, 2017 The diagnosis and treatment of benign prostatic obstruction (BPO) is based on a number of well-known lower urinary tract symptoms (LUTS) feared by all ageing males with functional testes. The ascent of modern urology turned this disease from lethal into an annoying but treatable health problem in the previous century.
Braeckman, Johan, Denis, Louis
openaire +4 more sources